KyriakieSarafoglouMD
Pediatric Endocrinology • Minneapolis, MNPediatric Adrenal Endocrinology, Pediatric Bone Metabolism Disorders, Sex Differentiation Endocrinology
Professor, Pediatrics, University of Minnesota Medical School
Dr. Sarafoglou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2450 Riverside Ave 12th floor
Minneapolis, MN 55454Phone+1 612-365-6777
Education & Training
NYU Grossman School of MedicineResidency, Pediatrics, 1996 - 1999
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 1990 - 1994
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Pediatrics, 1987 - 1990
University of AthensClass of 1984
Certifications & Licensure
NJ State Medical License 1993 - Present
MN State Medical License 2005 - 2025
NY State Medical License 1996 - 2006- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation Start of enrollment: 2015 Feb 01
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia Start of enrollment: 2018 Apr 10
- Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia Start of enrollment: 2018 Sep 06
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsThe relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.Eric M. Bomberg, O. Yaw Addo, Jennifer Kyllo, Maria Teresa Gonzalez-Bolanos, Aida M. Ltief
The Journal of Pediatrics. 2015-03-01 - 15 citationsTildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.Kyriakie Sarafoglou, Chris Barnes, Michael Huang, Erik A. Imel, Ivy-Joan Madu
The Journal of Clinical Endocrinology and Metabolism. 2021-10-21 - 13 citationsCrinecerfont Lowers Elevated Hormone Markers in Adults with 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.Richard J. Auchus, Kyriakie Sarafoglou, Patricia Y. Fechner, Maria G. Vogiatzi, Erik A. Imel
The Journal of Clinical Endocrinology and Metabolism. 2021-10-15
Journal Articles
- Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn ScreenTakara L Stanley, Kyriakie Sarafoglou, Rose Marino, Manmohan Kamboj, Bradley S Miller, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Novel Drug Reduces Steroid Need in Congenital Adrenal HyperplasiaJune 2nd, 2024- Glycomine’s Natural History Study Informs Potentially Lifesaving Update to Standard of Care for PMM2-CDG PatientsJune 29th, 2021
- Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and MetabolismJune 21st, 2021
- Join now to see all
Grant Support
- Partial Growth Hormone Insensitivity In Idiopathic Short Stature/Small-For-GestaNational Center For Research Resources2006–2009
- Comparison 17-Ohp Measured By Tandem Mass Spectroscopy VS Blood Serum In CAH PANational Center For Research Resources2008
- Aromatase Inhibitor In Males With Adrenal HyperplasiaEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
